Vol 4 n° 4 - Drug Development
Past issues Contributors How to publish Contributions and comments Home
 
C o n t e n t s >>> Next Content Drug discovery Drug discovery and mental illness Barry D. Lebowitz, Herbert W. Harris Subtyping of psychiatric disorders: implications for drug development Robert Cancro, E. Roy John, Robert Chabot, Leslie Prichep New directions for drug discovery in psychiatric disease Michael Spedding, Claude Sebban, Laurent Perret Sleep-wake mechanisms and drug discovery: sleep EEG as a tool for the development of CNS-acting drugs Luc Staner Proof of concept Simulating the anhedonia symptom of depression in animals Jean-Luc Moreau Neonatal disconnection of the rat hippocampus: a neurodevelopmental model of schizophrenia Barbara K. Lipska Neurogenetics of emotional reactivity to stress in animals Francis Chaouloff Human models as tools in the development of psychotropic drugs Christian Gilles, Therese Schunck, Gilles Erb, Izzie Jacques Namer, Yann Hodé, Jean-François Nedelec, Peter Boeijinga, Remy Luthringer, Jean-Paul Macher Objective markers of drug effects on brain function from recordings of scalp potential in healthy volunteers Peter H. Boeijinga Role of melatonin in the induction and maintenance of sleep Jean B. Fourtillan